Efficacy and safety of chronic antimicrobial suppression therapy for left ventricular assist device driveline infections: A single-center descriptive experience.
Christopher RadcliffeNatnael DoilichoYu Si NiuMatthew GrantPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
Our study suggests that CAS therapy for DLIs can be well tolerated, and future studies are needed to determine which patients merit suppression.